Cosmos Health (COSM) Projects $6M Revenue from Oliv18 Launch
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowCosmos Health (COSM) anticipates $6 million in revenue from the launch of its Oliv18 supplement. This projection is part of the company’s growth strategy in the health and wellness sector. The launch of Oliv18 aims to leverage increasing consumer demand for dietary supplements. This expected revenue could positively influence investor sentiment and market performance for Cosmos Health.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
